FR2469454A2 - Hybrid plasmid(s) of yeast - contg. DNA from 2 mu plasmid of yeast, URA3 plus gene and bacterial plasmid pBR 322 - Google Patents

Hybrid plasmid(s) of yeast - contg. DNA from 2 mu plasmid of yeast, URA3 plus gene and bacterial plasmid pBR 322 Download PDF

Info

Publication number
FR2469454A2
FR2469454A2 FR8006624A FR8006624A FR2469454A2 FR 2469454 A2 FR2469454 A2 FR 2469454A2 FR 8006624 A FR8006624 A FR 8006624A FR 8006624 A FR8006624 A FR 8006624A FR 2469454 A2 FR2469454 A2 FR 2469454A2
Authority
FR
France
Prior art keywords
plasmid
dna
yeast
pbr
ura3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8006624A
Other languages
French (fr)
Other versions
FR2469454B2 (en
Inventor
Michel Aigle
Hugues Blanc
Philippe Fournier
Claude Gerbaud
Michel Guerineau
Henri Heslot
Francois Lacroute
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP79400853A external-priority patent/EP0011562B2/en
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of FR2469454A2 publication Critical patent/FR2469454A2/en
Application granted granted Critical
Publication of FR2469454B2 publication Critical patent/FR2469454B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Abstract

Hybrid plasmid within the scope of the main claim of the parent patent, 78.32100, has all or part of the DNA of the 2 mu plasmid of yeast, DNA segment contg. URA3 plus gene and all or part of the DNA of the bacterial plasmid pBR 322. The DNA segment contg. the URA3 plus gene is pref. inserted into the DNA of plasmid pBR 322 at the Hind III site. The 2 mu DNA fragment is pref. the 2 mu D fragment and is inserted at the Eco R1 site of the DNA of plasmid pBR 322. Yeasts contg. the hybrid plasmids are also claimed. These plasmids allow the cloning of long DNA fragments while they themselves are shorter and hence are less fragile and easier to handle and extract.

Description

La présente addition concerne de nouveaux plasmides hybrides selon le brevet principal utiles pour modifier les propriétés des souches de microorganismes et notamment de levures ainsi que les microorganismes comportant ces plasmides hybrides. The present addition relates to new hybrid plasmids according to the main patent useful for modifying the properties of strains of microorganisms and in particular of yeasts as well as the microorganisms comprising these hybrid plasmids.

La présente addition concerne un plasmide hybride composé d'au moins tout ou partie de 1'ADN du plasmide 2 de levure, un segment d'ADN renfermant le gène URA3 de levure et un ADN du plasmide bactérien pBR 322. The present addition relates to a hybrid plasmid composed of at least all or part of the DNA of yeast plasmid 2, a DNA segment containing the yeast URA3 gene and a DNA of the bacterial plasmid pBR 322.

I1 peut être utile de rappeler que le plasmide 2 de levure est connu et une étude très complète peut en être trouvée dans "Viruses and Plasmid in Fungi" éditeur Paul A. Lemke, cet ouvrage pourra également être utilisé comme référence pour la définition de certains termes dont la définition complète ne serait pas donnée dans la présente description. It may be useful to recall that the yeast plasmid 2 is known and a very complete study can be found in "Viruses and Plasmid in Fungi" editor Paul A. Lemke, this work can also be used as a reference for the definition of certain terms whose complete definition would not be given in the present description.

Le gène URA3+ est le gène codant pour 1 'orotidine-5 '-phosphate-décarboxylase, en son absence la levure ne peut se développer que sur un milieu contenant de l'uracile.La présence ou l'absence de ce gène permet de "cribler" les levures en utilisant un milieu avec et sans uracile. The URA3 + gene is the gene encoding 1 'orotidine-5' -phosphate-decarboxylase, in its absence the yeast can only develop on a medium containing uracil. The presence or absence of this gene makes it possible to " to screen "yeasts using a medium with and without uracil.

Le plasmide pBR 322 est disponible à Bethesda
Research Laboratory Inc., Rockville, Maryland.
Plasmid pBR 322 is available at Bethesda
Research Laboratory Inc., Rockville, Maryland.

Dans un mode de réalisation des plasmides selon la présente invention, le segment d'ADN renfermant le gène URA3+ de levure est inséré dans 1'ADN du plasmide bactérien pBR 322, de préférence au niveau du site Hind III.  In one embodiment of the plasmids according to the present invention, the DNA segment containing the yeast URA3 + gene is inserted into the DNA of the bacterial plasmid pBR 322, preferably at the Hind III site.

Les sites de restriction Hind III correspondent aux endroits de la molécule ADN qui sont coupés par une enzyme particulière, l'endonucl se Hind III (qui sera appelée ci-après par abréviation Hind III). The Hind III restriction sites correspond to the places of the DNA molecule which are cut by a particular enzyme, the endonucl se Hind III (which will be called hereinafter by abbreviation Hind III).

Il n'y a qu'un site de restriction Hind III sur le plasmide pBR 322. There is only one Hind III restriction site on plasmid pBR 322.

Les plasmides selon la présente invention peuvent comporter l'intégralité de 1'ADN du plasmide 2 mais, de préférence, ne comportent qu'une partie de 1'ADN du plasmide 2 , la partie dénommée 2 D (l'autre partie étant dénommée 2 A), par rapport aux sites de restriction Eco R1. The plasmids according to the present invention can comprise the entire DNA of plasmid 2 but, preferably, contain only part of the DNA of plasmid 2, the part called 2 D (the other part being called 2 D A), relative to the Eco R1 restriction sites.

Les sites de restriction Eco R1 correspondent aux endroits de la molécule ADN qui sont coupés par une enzyme particulière, l'endonucléase Eco R1. The Eco R1 restriction sites correspond to the places in the DNA molecule which are cut by a particular enzyme, the Eco R1 endonuclease.

Dans un mode de réalisation particulièrement intéressant des plasmides de la présente invention, 1'ADN total ou la partie d'ADN du plasmide 2 est inséré au niveau du site Eco RI de 1'ADN du plasmide pBR 322. In a particularly advantageous embodiment of the plasmids of the present invention, the total DNA or the DNA part of the plasmid 2 is inserted at the Eco RI site of the DNA of the plasmid pBR 322.

Dans un autre mode de réalisation particulièrement intéressant de la présente invention, le plasmide hybride, en particulier au niveau de 1'ADN du plasmide bactérien, comporte l'insertion d'un ADN exogène provenant d'un organisme procaryote ou surtout d'un organisme eucaryote tel qu'une levure. In another particularly advantageous embodiment of the present invention, the hybrid plasmid, in particular at the level of the DNA of the bacterial plasmid, comprises the insertion of an exogenous DNA originating from a prokaryotic organism or especially from an organism eukaryote such as yeast.

On peut également prévoir dans le cadre de la présente addition des plasmides hybrides dans lesquels le plasmide 2p comporte une insertion d'un
ADN exogène provenant d'un organisme procaryote ou surtout eucaryote.
In the context of the present addition, it is also possible to provide hybrid plasmids in which the plasmid 2p includes an insertion of a
Exogenous DNA from a prokaryotic or especially eukaryotic organism.

Les plasmides vecteurs selon la presente invention peuvent être préparés par des techniques connues qui sont déjà décrites dans le brevet principal. The vector plasmids according to the present invention can be prepared by known techniques which are already described in the main patent.

Les plasmides hybrides peuvent être conservés tel quel ou dans une levure ou une bactérie od ils se multiplieront et pourront en être extraits à la demande. Hybrid plasmids can be stored as is or in yeast or bacteria where they will multiply and can be extracted on demand.

Ces plasmides peuvent être intégrés dans une levure par le procédé décrit dans le brevet principal. These plasmids can be integrated into a yeast by the method described in the main patent.

L'exemple suivant est destiné à illustrer un procédé de préparation de plasmides hybrides et de microorganismes selon la présente invention sans pour autant qu'il puisse être considéré comme limitant la porte de ladite invention. The following example is intended to illustrate a process for the preparation of hybrid plasmids and microorganisms according to the present invention without, however, that it can be considered as limiting the scope of said invention.

EXEMPLE
De façon analogue aux exemples 1 et 2 du brevet principal
- on prépare un plasmide pBR 322 avec le fragment portant le gène URA3+ inséré au niveau du site Hind III
- on effectue la digestion partielle du plasmide obtenu par l'enzyme Eco R1
- on effectue la digestion partielle du plasmide 2 de la souche Sacharomyces cerevisiae
FL 100 ATCC 28383 par l'enzyme Eco R1
- on mélange les deux produits de digestion après inhibition de l'enzyme Eco R1 et on ligature les fragments du mélange avec la ligase une nuit à 100C ;;
- on extrait les plasmides obtenus et on transforme une souche de levure S. cerevisiae réceptrice ura3, c'est-à-dire ne pouvant croître sans uracile, et on sélectionne les transformants capables de croître sur milieu sans uracile. De ces transformants URA3 on extrait les plasmides qui peuvent, comme cela a été décrit, être utilisés pour transformer une souche
Escherichia coli URA3 , laquelle par sélection des + souches URA3 obtenues constitue un réservoir de plasmides dont la structure est donnée dans les figures 1 et 2 ci-annexées.
EXAMPLE
Analogously to Examples 1 and 2 of the main patent
- a plasmid pBR 322 is prepared with the fragment carrying the URA3 + gene inserted at the Hind III site
- partial digestion of the plasmid obtained with the enzyme Eco R1 is carried out
- partial digestion of plasmid 2 of the Sacharomyces cerevisiae strain is carried out
FL 100 ATCC 28383 by the enzyme Eco R1
- The two digestion products are mixed after inhibition of the Eco R1 enzyme and the fragments of the mixture are ligated with the ligase overnight at 100C;
- The plasmids obtained are extracted and a strain of yeast S. cerevisiae ura3 receptor, that is to say that cannot grow without uracil, is transformed and the transformants capable of growing on medium without uracil are selected. Plasmids are extracted from these URA3 transformants which, as has been described, can be used to transform a strain
Escherichia coli URA3, which by selection of the + URA3 strains obtained constitutes a reservoir of plasmids, the structure of which is given in Figures 1 and 2 attached hereto.

La figure 1 représente le plasmide pFL 1 qui comporte 1'ADN du plasmide pBR 322 (représenté en traits pointillés) avec insertion de 1'ADN du gène +
URA3 (représenté en double trait) au niveau du site
Hind III de 1'ADN de pBR 322 et insertion au niveau du site Eco R1 de pBR 322 d'un fragment de 1'ADN du plasmide 2 , le fragment 2 D (fragment défini par rapport aux sites Eco R1).
FIG. 1 represents the plasmid pFL 1 which comprises the DNA of the plasmid pBR 322 (represented in dotted lines) with insertion of the DNA of the + gene
URA3 (shown in double line) at the site level
Hind III of pBR 322 DNA and insertion at the Eco R1 site of pBR 322 of a fragment of DNA from plasmid 2, the 2 D fragment (fragment defined with respect to Eco R1 sites).

I1 a été isolé 3 autres plasmides, pFL 2, + pFL 3et pFL 4. Pour pFL 2, 1'ADN du gene URA3 a l'orientation inverse, c'est-à-dire que le site Pst 1 se trouve à 0,8 kb du site Eco R1 pris comme origine. I1 was isolated 3 other plasmids, pFL 2, + pFL 3 and pFL 4. For pFL 2, the DNA of the URA3 gene has the opposite orientation, that is to say that the Pst 1 site is at 0, 8 kb from the Eco R1 site taken as origin.

Les plasmides pFL 3 et pFL 4 ont le fragment 2 D dans l'orientation inverse de celle observée respectivement pour pFL 1 et pFL 2. La longueur totale de ce plasmide est de 7,652 kb.The plasmids pFL 3 and pFL 4 have the 2 D fragment in the opposite orientation to that observed for pFL 1 and pFL 2 respectively. The total length of this plasmid is 7.652 kb.

Le plasmide pBR 322 porte un gène de
(Amp résistance à l'ampicilline (Ampr), gène qui code pour une pénicillinase. Dans une levure transformée par un plasmide de ce type (comme pFL 1 ou pFL 2) ce gêne bactérien est exprimé et on identifie une excrétion de pénicillinase par les levures transformées, ce qui montre l'intérêt des plasmides décrits dans la présente addition pour l'excrétion de protéines (enzymes en particulier), (CHEVALLIER M.R. et AIGLE M.,
Qualitative detection of penicillinase produced by yeast strains carrying chimeric yeast-coli plasmids.
Plasmid pBR 322 carries a gene for
(Amp resistance to ampicillin (Ampr), gene which codes for a penicillinase. In a yeast transformed by a plasmid of this type (like pFL 1 or pFL 2) this bacterial gene is expressed and one identifies an excretion of penicillinase by transformed yeasts, which shows the advantage of the plasmids described in the present addition for the excretion of proteins (enzymes in particular), (CHEVALLIER MR and AIGLE M.,
Qualitative detection of penicillinase produced by yeast strains carrying chimeric yeast-coli plasmids.

FEBS Letters, november 1979).FEBS Letters, November 1979).

Un autre avantage de ces plasmides est qu'ils démontrent que l'intégralité du plasmide 2 n'est pas indispensable à sa réplication et à son maintien dans la levure. L'avantage de cette construction est qu'elle permet d'envisager de cloner des fragments d'ADN étrangers de grande taille puisque le plasmide récepteur est plus petit. En effet, des plasmides de trop grande taille sont plus fragiles, plus difficiles à manipuler et à extraire des bactéries ou des levures. Another advantage of these plasmids is that they demonstrate that the entirety of plasmid 2 is not essential for its replication and for its maintenance in yeast. The advantage of this construction is that it makes it possible to consider cloning large foreign DNA fragments since the receptor plasmid is smaller. Indeed, too large plasmids are more fragile, more difficult to handle and to extract bacteria or yeasts.

De façon identique, on obtient le plasmide pMA 1 représenté à la figure 2. Similarly, the plasmid pMA 1 is obtained, represented in FIG. 2.

Ce plasmide a la même structure que les précédents mais présente l'intégralité de 1'ADN du plasmide 2 (2 A + 2 D) au lieu du fragment 2 D.  This plasmid has the same structure as the previous ones but has the entire DNA of plasmid 2 (2 A + 2 D) instead of the 2 D fragment.

Claims (9)

REVENDICATIONS 1) Plasmide hybride selon la revendication 1 du brevet principal comportant au moins tout ou partie de 1'ADN du plasmide 2p de levure, un segment d'ADN renfermant le gène URA3 et tout ou partie de 1'ADN du plasmide bactérien pBR 322. 1) Hybrid plasmid according to claim 1 of the main patent comprising at least all or part of the DNA of the yeast plasmid 2p, a DNA segment containing the URA3 gene and all or part of the DNA of the bacterial plasmid pBR 322. 2) Plasmide selon la revendication 1, caractérisé en ce que le segment d'ADN renfermant le gène URA3+ de levure est inséré dans 1'ADN du plasmide bactérien pBR 322. 2) Plasmid according to claim 1, characterized in that the DNA segment containing the yeast URA3 + gene is inserted into the DNA of the bacterial plasmid pBR 322. 3) Plasmide selon la revendication 2, caractérisé en ce que le segment d'ADN renfermant le gène URA3 de levure est inséré dans 1'ADN du plasmide bactérien pBR 322 au niveau du site Hind III. 3) Plasmid according to claim 2, characterized in that the DNA segment containing the yeast URA3 gene is inserted into the DNA of the bacterial plasmid pBR 322 at the Hind III site. 4) Plasmide selon l'une des revendications 1 à 3, caractérisé en ce qu'il comporte le fragment d'ADN 2 D du plasmide 2p. 4) Plasmid according to one of claims 1 to 3, characterized in that it comprises the 2 D DNA fragment of the plasmid 2p. 5) Plasmide selon l'une des revendications 1 à 3, caractérisé en ce qu'il comporte tout 1'ADN du plasmide 2p. 5) Plasmid according to one of claims 1 to 3, characterized in that it comprises all of the DNA of the plasmid 2p. 6) Plasmide selon l'une des revendications 1 à 5, caractérisé en ce que 1'ADN total ou.la partie d'ADN du plasmide 2 est inséré au niveau du site 6) Plasmid according to one of claims 1 to 5, characterized in that the total DNA ou.la portion of DNA from plasmid 2 is inserted at the site Eco R1 de 1'ADN du plasmide pBR 322.Eco R1 of the DNA of the plasmid pBR 322. 7) Plasmide selon l'une des revendications 1 à 6, caractérisé en ce qu'il comporte l'insertion d'un ADN d'un organisme procaryote ou eucaryote en plus du segment d 'ADN renfermant le gène URA3 de levure. 7) Plasmid according to one of claims 1 to 6, characterized in that it comprises the insertion of DNA from a prokaryotic or eukaryotic organism in addition to the DNA segment containing the yeast URA3 gene. 8) Un microorganisme comportant un plasmide hybride selon l'une des revendications 1 à 7. 8) A microorganism comprising a hybrid plasmid according to one of claims 1 to 7. 9) Une levure selon la revendication 8. 9) A yeast according to claim 8.
FR8006624A 1979-11-13 1980-03-25 Hybrid plasmid(s) of yeast - contg. DNA from 2 mu plasmid of yeast, URA3 plus gene and bacterial plasmid pBR 322 Granted FR2469454A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP79400853A EP0011562B2 (en) 1978-11-14 1979-11-13 Saccharomyces cer. transformed by a plasmid

Publications (2)

Publication Number Publication Date
FR2469454A2 true FR2469454A2 (en) 1981-05-22
FR2469454B2 FR2469454B2 (en) 1985-05-03

Family

ID=8186512

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8006624A Granted FR2469454A2 (en) 1979-11-13 1980-03-25 Hybrid plasmid(s) of yeast - contg. DNA from 2 mu plasmid of yeast, URA3 plus gene and bacterial plasmid pBR 322

Country Status (1)

Country Link
FR (1) FR2469454A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984004539A1 (en) * 1983-05-19 1984-11-22 Transgene Sa Production of catechol 2,3-oxygenase by means of yeasts, plasmide for the implementation thereof and application
EP0152358A1 (en) * 1984-02-16 1985-08-21 Transgene S.A. Yeast-expression vectors for interleukin-2, transformed yeasts and process for the preparation of interleukin-2
FR2561662A2 (en) * 1984-03-22 1985-09-27 Transgene Sa Unit for expressing catechol 2,3-oxygenase in yeasts and a strain labelled by means of this expression unit

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984004539A1 (en) * 1983-05-19 1984-11-22 Transgene Sa Production of catechol 2,3-oxygenase by means of yeasts, plasmide for the implementation thereof and application
EP0152358A1 (en) * 1984-02-16 1985-08-21 Transgene S.A. Yeast-expression vectors for interleukin-2, transformed yeasts and process for the preparation of interleukin-2
FR2559782A1 (en) * 1984-02-16 1985-08-23 Transgene Sa EXPRESSION VECTOR IN YEASTS OF INTERLEUKIN-2, PROCESSED YEASTS AND PROCESS FOR THE PREPARATION OF INTERLEUKIN-2
WO1985003723A1 (en) * 1984-02-16 1985-08-29 Transgene S.A. Vector for the expression in yeasts of interleukine-2, transformed yeasts and method for preparing interleukine-2
FR2561662A2 (en) * 1984-03-22 1985-09-27 Transgene Sa Unit for expressing catechol 2,3-oxygenase in yeasts and a strain labelled by means of this expression unit

Also Published As

Publication number Publication date
FR2469454B2 (en) 1985-05-03

Similar Documents

Publication Publication Date Title
EP0011562B1 (en) Saccharomyces cer. transformed by a plasmid
Ghadessy et al. Stonustoxin is a novel lethal factor from stonefish (Synanceja horrida) venom: cDNA cloning and characterization
FR2532656A2 (en) New cloning and expression vector, yeast and bacteria transformed using this vector.
EP0193555B1 (en) Application of antibiotics of the phleomycine family as selection agent in the field of genetic engineering
Quyen et al. High-level formation of active Pseudomonas cepacia lipase after heterologous expression of the encoding gene and its modified chaperone in Escherichia coli and rapid in vitro refolding
AU671669B2 (en) Transgenic pathogen-resistant organism
CN108085306B (en) Zearalenone degrading enzyme mutant and encoding gene and application thereof
JP3749628B2 (en) Luciferase and method for measuring intracellular ATP using the same
Trabesinger-Ruef et al. Pseudogenes in ribonuclease evolution: a source of new biomacromolecular function?
CN107099520B (en) Zearalenone degrading enzyme and coding gene and application thereof
US20050142650A1 (en) Fungus-origin lysyl oxidases
FR2469454A2 (en) Hybrid plasmid(s) of yeast - contg. DNA from 2 mu plasmid of yeast, URA3 plus gene and bacterial plasmid pBR 322
EP0594771B1 (en) Nucleotide sequences and resistance proteins cycloheximide
Yurimoto et al. Characterization and high-level production of D-amino acid oxidase in Candida boidinii
EP0672124B1 (en) Use of a dna sequence coding for an oxalic acid degrading protein as a selection gene
Chan et al. Construction of inducible expression vector pDNLS-22n containing P. aeruginosa PAO1 ChiC
Serrano et al. Purification of ferredoxin-NADP+ oxidoreductase from cyanobacteria by affinity chromatography on 2′, 5′-ADP-Sepharose 4B
EP0396436B1 (en) Improved yeast strains for the production of mature heterologous proteins, in particular of hirudin
CA2285041A1 (en) Cassette for the transformation of yeast
van der Giezen et al. The hydrogenosomal malic enzyme from the anaerobic fungus Neocallimastix frontalis is targeted to mitochondria of the methylotrophic yeast Hansenula polymorpha
RU2144957C1 (en) Recombinant plasmid dna ppins07 encoding fused polypeptide containing human proinsulin and strain of bacterium escherichia coli - producer of fused polypeptide containing human proinsulin
US5527701A (en) Aspergillus terreus blasticidin S deaminase, a blasticidin S deaminase gene, a vector incorporating said gene and a transformant containing said vector
Ölschläger et al. Identification of factors impeding the production of a single-chain antibody fragment in Escherichia coli by comparing in vivo and in vitro expression
Ganesa et al. Purification and molecular properties of the toxin coded by Ustilagomaydis virus P4
US20110189753A1 (en) Intracellular Production of a Nuclease